Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy

Inclusion Criteria: * Aged 18 years or older * A pregnancy confirmed as 35-49 days gestational age through transvaginal ultrasound * Seeking termination of pregnancy * Speak English or Spanish * Willing to potentially delay abortion for 1-2 weeks * Willing and able to comply with study protocol and accept that the study regimen may not successfully terminate the pregnancy thus a uterine aspiration would be required to complete the abortion. * Willing to delay contraception until completion of abortion Exclusion Criteria: * People with pregnancy over 49 days gestational age * Twin or higher multiple pregnancy * Medical contraindications to medical abortion per the mifepristone U.S. Food and Drug Administration label * Confirmed or suspected ectopic pregnancy * Vaginal bleeding in current pregnancy * Pregnancy of unknown location * IUD or contraceptive implant in place * History of allergy to atorvastatin or misoprostol * History of myositis * Currently taking or planning on taking medications during the study that interact with HMG co-A reductase inhibitors (e.g., diltiazem, erythromycin, azoles, gemfibrozil or another fibrate) * Unable to return for clinic-based follow-up * Currently breastfeeding * Already taking an HMG co-A reductase inhibitor \[37\] or plan to take one outside the study drug during the trial (Fluvastatin, lovastatin, pitavastatin, pravastatin, simvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, simvastatin or rosuvastatin. * U…